Concourse Financial Group Securities, Inc. Heron Therapeutics, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 1,280 shares of HRTX stock, worth $2,227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,280
Previous 1,580
18.99%
Holding current value
$2,227
Previous $5,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HRTX
# of Institutions
174Shares Held
121MCall Options Held
80.4KPut Options Held
94.9K-
Rubric Capital Management LP New York, NY26.7MShares$46.5 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.85MShares$15.4 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.72MShares$15.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$14.5 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$12.2 Million28.8% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $207M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...